NCT04230772

Brief Summary

In this study, the investigators will compare the clinical outcomes of the natural orifice specimen extraction surgery versus traditional robotic-assisted surgery in the treatment of colorectal cancer.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
550

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2021

Typical duration for not_applicable

Geographic Reach
1 country

7 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 14, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 18, 2020

Completed
1 year until next milestone

Study Start

First participant enrolled

February 1, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

January 22, 2020

Status Verified

January 1, 2020

Enrollment Period

11 months

First QC Date

January 14, 2020

Last Update Submit

January 19, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of surgical complications

    Complication rate of surgery within 30 days after surgery.

    30 days

Secondary Outcomes (15)

  • The variation of C-reactive protein

    Preoperative 3 days and postoperative 1, 3, and 7 days

  • The variation of interleukin-6(IL-6)

    Preoperative 3 days and postoperative 1, 3, and 7 days

  • The variation of interleukin-10(IL-10)

    Preoperative 3 days and postoperative 1, 3, and 7 days

  • The variation of cortisol

    Preoperative 3 days and postoperative 1, 3, and 7 days

  • The variation of lymphocyte subsets count of CD3, CD4 and CD8

    Preoperative 3 days and postoperative 1, 3, and 7 days

  • +10 more secondary outcomes

Study Arms (2)

Natural Orifice Specimen Extraction Surgery

EXPERIMENTAL

Natural orifice specimen extraction surgery will performed in patients assigned to this group.

Procedure: Natural Orifice Specimen Extraction Surgery

Traditional Robotic-assisted Surgery

ACTIVE COMPARATOR

Traditional robotic-assisted surgery will performed in patients assigned to this group.

Procedure: Traditional Robotic-assisted Surgery

Interventions

In the experimental group, patients will be performed robotic colorectal resection with natural orifice specimen extraction.

Natural Orifice Specimen Extraction Surgery

In the active comparator group, patients will be performed traditional robotic-assisted colorectal resection.

Traditional Robotic-assisted Surgery

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 and ≤ 80 years;
  • Performance status of 0 or 1 on ECOG (Eastern Cooperative Oncology Group) scale;
  • Histological or cytological confirmation of colorectal adenocarcinoma;
  • High rectal and sigmoid cancer with the lower margin of the tumor greater than 10 cm from the anal dentate line;
  • T1-3N0M0 at preoperative evaluation according to the American Joint Committee on Cancer (AJCC) Cancer Staging Manual 8th Edition, Transvaginal NOSES procedure w specimen with a circumferential diameter of \<5 cm;
  • Preoperative examination did not suggest distant metastasis, implantation or invasion of adjacent organs;
  • Cardiopulmonary liver and kidney function can withstand surgery;
  • Written informed consent for participation in the trial.

You may not qualify if:

  • Not suitable for robot laparoscopic surgery;
  • The tumor is too large to be pulled out through the anus or vagina;
  • Simultaneous multiple primary cancer;
  • Emergency surgery due to complication (bleeding, obstruction or perforation) caused by primary cancer
  • Women with acute gynecological infections, vaginal deformities, unmarried and infertile women and women who are married and plan to get pregnant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Chinese PLA General Hospital (301 Hospital) China

Beijing, Beijing Municipality, 100036, China

RECRUITING

Nanfang Hospital, Southern Medical University

Guangzhou, Guangdong, 510515, China

RECRUITING

The Second Xiangya Hospital of Central South University

Changsha, Hunan, 410008, China

RECRUITING

First Affiliated Hospital of Gannan Medical College

Ganzhou, Jiangxi, 341 000, China

RECRUITING

The First Affiliated Hospital of Nanchang University

Nanchang, Jiangxi, 360006, China

RECRUITING

The Second Affiliated Hospital of Nanchang University

Nanchang, Jiangxi, 360006, China

RECRUITING

Zhongshan Hospital, Fudan University

Shanghai, Shanghai Municipality, 200032, China

RECRUITING

Related Publications (1)

  • Luo R, Zheng F, Zhang H, Zhu W, He P, Liu D. Robotic natural orifice specimen extraction surgery versus traditional robotic-assisted surgery (NOTR) for patients with colorectal cancer: a study protocol for a randomized controlled trial. Trials. 2021 Feb 6;22(1):121. doi: 10.1186/s13063-021-05077-z.

MeSH Terms

Conditions

Colorectal NeoplasmsNeoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Taiyuan Li, M.D., Ph.D

    Department of General Surgery, The First Affiliated Hospital of Nanchang University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Taiyuan Li, M.D., Ph.D

CONTACT

Dongning Liu, M.D., Ph.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof., Chief physician, Head of The Fifth Department of General Surgery

Study Record Dates

First Submitted

January 14, 2020

First Posted

January 18, 2020

Study Start

February 1, 2021

Primary Completion

December 31, 2021

Study Completion

December 31, 2022

Last Updated

January 22, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share

Locations